Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
---|---|---|---|---|---|---|---|
ENST00000432560 | AP1B1-208 | 4146 | - | ENSP00000400065 | 939 (aa) | - | Q10567 |
ENST00000421126 | AP1B1-207 | 1908 | - | ENSP00000400022 | 578 (aa) | - | C9J1E7 |
ENST00000472057 | AP1B1-209 | 727 | - | - | - (aa) | - | - |
ENST00000402502 | AP1B1-203 | 2935 | - | ENSP00000386071 | 939 (aa) | - | Q10567 |
ENST00000317368 | AP1B1-201 | 3903 | - | ENSP00000319361 | 919 (aa) | - | Q10567 |
ENST00000415447 | AP1B1-205 | 2838 | - | ENSP00000387612 | 939 (aa) | - | Q10567 |
ENST00000482818 | AP1B1-211 | 3560 | - | - | - (aa) | - | - |
ENST00000415756 | AP1B1-206 | 519 | - | ENSP00000392735 | 173 (aa) | - | H7C034 |
ENST00000473606 | AP1B1-210 | 560 | - | - | - (aa) | - | - |
ENST00000405198 | AP1B1-204 | 3838 | - | ENSP00000384194 | 949 (aa) | - | Q10567 |
ENST00000357586 | AP1B1-202 | 4176 | - | ENSP00000350199 | 949 (aa) | - | Q10567 |
ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
---|---|---|---|---|---|---|---|---|---|
ENSG00000100280 | rs2267137 | 22 | 29397536 | C | High light scatter reticulocyte count | 27863252 | [0.015-0.03] unit decrease | 0.02256278 | EFO_0007986 |
ENSG00000100280 | rs2267137 | 22 | 29397536 | C | High light scatter reticulocyte percentage of red cells | 27863252 | [0.016-0.03] unit decrease | 0.02315204 | EFO_0007986 |
ENSG00000100280 | rs2267138 | 22 | 29397652 | ? | Myopia (pathological) | 23049088 | [NR] | EFO_0004207 | |
ENSG00000100280 | rs13056435 | 22 | 29412174 | C | Heel bone mineral density | 28869591 | [0.038-0.071] unit increase | 0.0548708 | EFO_0009270 |
ENSG00000100280 | rs13056435 | 22 | 29412174 | C | Heel bone mineral density | 28869591 | [0.036-0.06] unit increase | 0.0480958 | EFO_0009270 |
ENSG00000100280 | rs174775 | 22 | 29395245 | G | Immature fraction of reticulocytes | 27863252 | [0.017-0.032] unit decrease | 0.02447633 | EFO_0007986 |
ENSG00000100280 | rs75337432 | 22 | 29337521 | ? | Heel bone mineral density | 30048462 | [0.032-0.047] unit increase | 0.0395155 | EFO_0009270 |
ENSG00000100280 | rs13056435 | 22 | 29412174 | ? | Heel bone mineral density | 30048462 | [0.031-0.046] unit increase | 0.0387759 | EFO_0009270 |
ENSG00000100280 | rs34583478 | 22 | 29339658 | C | Heel bone mineral density | 30598549 | [0.024-0.038] unit increase | 0.0309925 | EFO_0009270 |
ENSG00000100280 | rs34583478 | 22 | 29339658 | ? | Heel bone mineral density | 30595370 | EFO_0009270 |
Ensembl ID | Gene Symbol | Coverage | Identiy | Ortholog | Gene Symbol | Coverage | Identiy | Species |
---|---|---|---|---|---|---|---|---|
ENSG00000100280 | AP1B1 | 100 | 99.827 | ENSMUSG00000009090 | Ap1b1 | 100 | 96.925 | Mus_musculus |
Go ID | Go_term | PubmedID | Evidence | Category |
---|---|---|---|---|
GO:0000139 | Golgi membrane | - | TAS | Component |
GO:0005215 | transporter activity | 7987321. | TAS | Function |
GO:0005515 | protein binding | 9733768.23415225.24843023. | IPI | Function |
GO:0005765 | lysosomal membrane | - | TAS | Component |
GO:0005794 | Golgi apparatus | - | IDA | Component |
GO:0005829 | cytosol | - | IDA | Component |
GO:0005829 | cytosol | - | TAS | Component |
GO:0006886 | intracellular protein transport | - | IEA | Process |
GO:0007368 | determination of left/right symmetry | - | IEA | Process |
GO:0007507 | heart development | - | IEA | Process |
GO:0016192 | vesicle-mediated transport | - | IEA | Process |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | - | TAS | Process |
GO:0019901 | protein kinase binding | - | ISS | Function |
GO:0030131 | clathrin adaptor complex | - | IEA | Component |
GO:0030276 | clathrin binding | - | IEA | Function |
GO:0030659 | cytoplasmic vesicle membrane | - | TAS | Component |
GO:0030665 | clathrin-coated vesicle membrane | - | IEA | Component |
GO:0032588 | trans-Golgi network membrane | - | TAS | Component |
GO:0043231 | intracellular membrane-bounded organelle | - | IDA | Component |
GO:0050690 | regulation of defense response to virus by virus | - | TAS | Process |